Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2017-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inclusion and exclusion criteria for fetal repair of MMC was established by the Management of Myelomeningocele Study (MOMS Trial) and these criteria are the standard of care throughout the United States. These criteria state exclusion for hypertension and diabetes which are known co-morbidities for obesity. Investigators plan to expand one exclusion criteria for open fetal repair surgery. Currently, an exclusion factor is a maternal BMI of 35.0 and greater.Investigators will maintain all other inclusion and exclusion criteria (including excluding for hypertension and diabetes) with the exception of expanding the BMI to include mothers with a BMI of 35.0 to 40.0. Co-morbidities of the research group will be compared to the comorbidities of the mothers published in the MOMS trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy

NCT05033275

Infant of Diabetic Mother Sacral Agenesis

TERMINATED

Maternal-fetal Immune Responses to Fetal Surgery

NCT04484441

Spina Bifida Congenital Diaphragmatic Hernia Lower Urinary Tract Obstructive Syndrome +1 more

ACTIVE_NOT_RECRUITING

MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study

NCT00763672

Pregnancy Primiparity Hypertension +2 more

COMPLETED NA

Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be

NCT01322529

Pregnancy Pregnancy Complications

COMPLETED

Newborns of Obese Mothers

NCT02681588

Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The MOMS trial proved prenatal repair of myelomeningocele was an advantage over postnatal repair for the fetus/neonate/child and is the standard of care for maternal/fetal dyads who meet the inclusion exclusion criteria. Investigators plan to maintain all inclusion exclusion criteria for open fetal repair surgery of myelomeningocele with one exception, the expansion of the maternal BMI to 40.0. This population of mothers with a BMI of 35.0 to 40.0 have not been studied. The morbidities of these mothers will be compared to morbidities of mothers with a BMI less than or equal to 34.9 currently in the scientific literature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myelomeningocele Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BMI 35.0 to 40.0

Mothers who meet all inclusion exclusion criteria for open fetal repair of myelomeningocele except BMI.

These mothers have a BMI between 35.0 and 40.0

Group Type EXPERIMENTAL

Open Fetal Repair of Myelomeningocele

Intervention Type PROCEDURE

Open Fetal Repair of Myelomeningocele when mothers BMI is elevated

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Open Fetal Repair of Myelomeningocele

Open Fetal Repair of Myelomeningocele when mothers BMI is elevated

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Maternal BMI 35.0 to 40.0
* No maternal documented co-morbidities
* Fetal MMC begins between thoracic 1 and sacral 1, on the spinal column.
* Evidence of fetal hindbrain herniation (hindbrain is being pulled down the spinal column).
* A gestational age is between 19 weeks 0 days and 26 weeks with evidence of placental membrane fusion.
* Documented normal fetal karyotype.

Exclusion Criteria

* History of maternal alloimmunization problem
* Kell sensitization
* Risk of preterm birth
* History of spontaneous preterm birth
* Cervix \<20mm in length
* Presence of cerclage
* Placental problem
* History of placental abruption
* Placental Previa
* Body-mass index of 40.1 or more
* Maternal contraindication to surgery
* Insulin-dependent pregestational diabetes
* Hypertension or preeclampsia
* HIV, hepatitis-B, or hepatitis-C positive
* Other medical condition of risk to mother
* Uterine problem
* Previous hysterotomy in the active uterine segment
* Severe fibroids
* Uterine malformation (bicornuate, arcuate, unicornuate, didelphys)
* No support person for periprocedural period
* Inadequate support at home for pregnancy
* Inadequate understanding of risks and benefits of fetal surgery
* Inability to comply with medical restrictions, follow up after fetal surgery
* Multiple gestation pregnancy (twins, triplets, etc.)
* A fetal anomaly unrelated to myelomeningocele (heart defect, lung lesions)
* Severe fetal kyphosis \>30 degrees (curvature of the back)

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No